NR1 is a small molecule inhibitor that selectively targets Rheb and mTORC1, suppressing pS6K1 T389 phosphorylation while enhancing pAKT S473 phosphorylation. This tool compound is used in vitro and in vivo to study mTOR signaling dynamics in cancer and metabolic research.